Key Takeaways Tutor Perini won a $155M contract to build the Diego Rivera Arts Center at City College of San Francisco.The award strengthens TPC's education and public-sector backlog, enhancing visibility and revenue growth.TPC shares rose 57.3% in six months as strong funding and disciplined bidding support sustained growth.Tutor Perini Corporation (TPC) strengthened its backlog with a new contract award valued at approximately $155 million. The company’s subsidiary, Rudolph and Sletten, has been selected ...

Key Takeaways EverQuote benefited from recovering carrier spending and higher engagement across its insurance marketplace.Orion Group was supported by steady infrastructure demand and improving project pipeline visibility.Standard Motor gained from resilient aftermarket demand and progress integrating the Nissens business.Small-cap investing requires patience and selectivity, particularly when market volatility reshapes investor priorities. While broad sentiment can shift quickly, companies with visible rev ...

Wage growth recently outpaced inflation, offering short-term relief that has yet to translate into sustained financial security.Inflation is easing overall, but consumers are still paying more for food, beverages and everyday retail goods.After weeks of a government shutdown, economic data continue to roll in, and the latest inflation figures sketch a picture that is far from definitive.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information ...

Despite rising costs and expected market volatility, wealthy Americans plan to keep spending and investing steady in 2026. Find Out: 4 Secrets of the Truly Wealthy, According To Dave Ramsey Read Next: 6 Subtly Genius Moves All Wealthy People Make With Their Money Here’s why — and what it means for your own financial strategy. Why Wealthy Investors Aren’t Changing Risk in 2026 According to a Schwab survey of its high-net-worth clients, more than 75% plan to maintain their current portfolio risk levels i ...

The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE:MRK) drugs with potential blockbuster sales.Merck's cholesterol treatment enlicitide decanoate and cancer therapy sacituzumab tirumotecan (sac-TMT) have been reportedly selected for the FDA Commissioner's National Priority Voucher (CNPV) program, which accelerates regulatory decisions for medicines deemed critical to public health or national interests.If finalized, the drugs would becom ...

CALGARY, Alberta, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cygnet Energy Ltd. ("Cygnet") and Kiwetinohk Energy Corp. ("Kiwetinohk") (TSX: KEC) are pleased to announce the completion of the acquisition of Kiwetinohk by Cygnet. As previously announced, all outstanding common shares of Kiwetinohk (the "KEC Shares") were acquired by Cygnet pursuant to a plan of arrangement under Section 192 of the Canada Business Corporations Act (the "Arrangement") for $24.75 per KEC Share. As part of the Arrangement, certain investm ...

Core Insights - Eli Lilly is set to launch a new pill named orforglipron next year [1] Company Summary - The new medication, orforglipron, is part of Eli Lilly's ongoing efforts to expand its product portfolio [1]

Cookie Settings We use cookies to analyze user behavior in order to constantly improve the website for you. View our Privacy Policy and Terms of Use. Necessary Analytics ...

About Us Reviews Site Map Your Ad Choices Advertising Contact us IBD Stock Charts IBD Stock Checkup Stock Quotes Stock Market Today The Big Picture My Stock Lists Information in Investor's Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, in ...

The stock market's Thursday rally hasn't come easy. The market benchmark index was up 1.4% in recent trading. The Dow was up 374 points, or 0.9%. The Nasdaq Composite was up 2%. The S&P and Nasdaq were on track for their best CPI release day since Jan. 15, according to Dow Jones Market Data. The market benchmark index was up 1.3% in recent trading. The Dow was up 420 points, or 0.9%. The Nasdaq Composite was up 1.9%. AI stocks rallied in the wake of Micron Technology's earnings, while the rest of the market ...